Home Atalanta Therapeutics

Atalanta Therapeutics

In operation
Series B
Biological New Drug Developer

Basic Information

Atalanta Therapeutics was founded to address the urgent global need for interventions to treat neurodegenerative diseases. The groundbreaking discoveries of our founders in RNA interference provide a powerful therapeutic approach to halt diseases at their source.
Atalanta Therapeutics, Inc.
Boston,Massachusetts,United States of America
15~50 people
January 01, 2018
contact@atalantatx.com